The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
Open Access
- 15 December 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (2), 195-197
- https://doi.org/10.1016/j.jcf.2020.12.007
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health
This publication has 7 references indexed in Scilit:
- The global impact of SARS-CoV-2 in 181 people with cystic fibrosisJournal of Cystic Fibrosis, 2020
- SARS-CoV-2 Transmission and the Risk of Aerosol-Generating ProceduresAmerican Journal of Respiratory and Critical Care Medicine, 2020
- The Impact of COVID-19 on Dermatology Clinical TrialsJournal of Investigative Dermatology, 2020
- SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial networkEuropean Respiratory Journal, 2020
- SARS-CoV-2 Transmission and the Risk of Aerosol Generating Procedures.2020
- Impact of COVID-19 on oncology clinical trialsNature Reviews Drug Discovery, 2020
- A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisJournal of Cystic Fibrosis, 2020